Eastwood, M C, Busby, J, Jackson, D J, Pavord, I D, Hanratty, C E, Djukanovic, R, Woodcock, A, Walker, S, Hardman, T C, Arron, J R, Choy, D F, Bradding, P, Brightling, C E, Chaudhuri, R, Cowan, D, Mansur, A H, Fowler, S J, Howarth, P, Lordan, J, Menzies-Gow, A, Harrison, T, Robinson, D S, Holweg, C T J, Matthews, J G, Heaney, L G & RASPUK Investigators 2023, ' A randomized trial of a composite T2-biomarker strategy adjusting corticosteroid treatment in severe asthma: a post-hoc analysis by sex ', The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 4, pp. 1233-1242.e5 . https://doi.org/10.1016/j.jaip.2022.12.019 RASPUK Investigators 2023, ' A randomised trial of a T2-composite-biomarker strategy adjusting corticosteroidtreatment in severe asthma, a post-hoc analysis by sex ', The journal of allergy and clinical immunology. In practice . https://doi.org/10.1016/j.jaip.2022.12.019
The Lancet. Respiratory Medicine Heaney, L G, Busby, J, Hanratty, C E, Djukanovic, R, Woodcock, A, Walker, S M, Hardman, T C, Arron, J R, Choy, D F, Bradding, P, Brightling, C E, Chaudhuri, R, Cowan, D C, Mansur, A H, Fowler, S J, Niven, R M, Howarth, P H, Lordan, J L, Menzies-Gow, A, Harrison, T W, Robinson, D S, Holweg, C T J, Matthews, J G & Pavord, I D 2020, ' Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial ', The Lancet Respiratory Medicine, vol. 9, no. 1, pp. 57-68 . https://doi.org/10.1016/S2213-2600(20)30397-0 Investigators for the MRC Refractory Asthma Stratification Programme 2020, ' Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma : a multicentre, single-blind, parallel group, randomised controlled trial ', The Lancet. Respiratory medicine, vol. 9, no. 1, pp. 57-68 . https://doi.org/10.1016/S2213-2600(20)30397-0
investigators for the MRC Refractory Asthma Stratification Program 2021, ' Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma ', The European respiratory journal . https://doi.org/10.1183/13993003.00768-2021 Busby, J, Matthews, J G, Chaudhuri, R, Pavord, I D, Hardman, T C, Arron, J R, Bradding, P, Brightling, C E, Choy, D F, Cowan, D C, Djukanovic, R, Hanratty, C E, Harrison, T W, Holweg, C T, Howarth, P H, Fowler, S J, Lordan, J L, Mansur, A H, Menzies-Gow, A, Niven, R M, Robinson, D S, Walker, S M, Woodcock, A & Heaney, L G 2022, ' Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma ', European Respiratory Journal, vol. 59, no. 4, 2100768 . https://doi.org/10.1183/13993003.00768-2021
ERJ Open Research article-version (VoR) Version of Record ERJ Open Research, Vol 7, Iss 3 (2021) Butler, C A, McMichael, A J, Honeyford, K, Wright, L, Logan, J, Holmes, J, Busby, J, Hanratty, C E, Yang, F, Smith, S, Murray, K, Chaudhuri, R & Heaney, L G 2021, ' Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy ', ERJ Open Research, vol. 7, no. 3, 00273 . https://doi.org/10.1183/23120541.00273-2021